Skip to main content
main-content

Zeitschrift

Breast Cancer Research

Breast Cancer Research 2/2005

Sonderheft 2/2005

The Third International Symposium on the Molecular Biology of Breast Cancer

Inhaltsverzeichnis ( 155 Artikel )

01.06.2005 | Oral Presentation | Sonderheft 2/2005

The challenges in translating present knowledge of the molecular biology of breast cancer into clinical use

01.06.2005 | Oral Presentation | Sonderheft 2/2005

Stromal and epithelial TGF-β signaling in mammary tumorigenesis

01.06.2005 | Oral Presentation | Sonderheft 2/2005

Genomic analysis of human breast cancer in families and populations

01.06.2005 | Oral Presentation | Sonderheft 2/2005

Abstract withdrawn

01.06.2005 | Oral Presentation | Sonderheft 2/2005

ATM mutations associated with breast cancer

01.06.2005 | Oral Presentation | Sonderheft 2/2005

DNA damage response pathways in cancer causation and treatment

01.06.2005 | Oral Presentation | Sonderheft 2/2005

SNPS in putative regulatory loci controlling gene expression in cancer

01.06.2005 | Oral Presentation | Sonderheft 2/2005

Potential mechanisms whereby estrogens induce breast cancer in women

01.06.2005 | Oral Presentation | Sonderheft 2/2005

The future of breast cancer prevention

01.06.2005 | Oral Presentation | Sonderheft 2/2005

Targeting estrogen to kill ER-positive and ER-negative breast cancer

01.06.2005 | Oral Presentation | Sonderheft 2/2005

ERβ in normal and malignant breast

01.06.2005 | Oral Presentation | Sonderheft 2/2005

Molecular approaches to understanding pregnancy-induced protection against breast cancer

01.06.2005 | Oral Presentation | Sonderheft 2/2005

Predicting response/resistance to endocrine therapy for breast cancer

01.06.2005 | Oral Presentation | Sonderheft 2/2005

Genetic and epigenetic changes in early carcinogenesis

01.06.2005 | Oral Presentation | Sonderheft 2/2005

A breast cancer progression model: the importance of three-dimensional tissue architecture and metalloproteinases

01.06.2005 | Oral Presentation | Sonderheft 2/2005

Genomic and transcriptional events associated with poor clinical responses to conventional therapies

01.06.2005 | Oral Presentation | Sonderheft 2/2005

The role of the tumor microenvironment in breast cancer progression

01.06.2005 | Oral Presentation | Sonderheft 2/2005

Biological features and xenograft models of a very early human premalignant breast lesion

01.06.2005 | Oral Presentation | Sonderheft 2/2005

Regulation of epithelial cell polarity during carcinogenesis

01.06.2005 | Oral Presentation | Sonderheft 2/2005

Expression profiling of peripheral blood cells for early detection

01.06.2005 | Oral Presentation | Sonderheft 2/2005

Stem cells in human breast development and cancer

01.06.2005 | Oral Presentation | Sonderheft 2/2005

Molecular distinctions among ERBB2-overexpressing breast cancers

01.06.2005 | Oral Presentation | Sonderheft 2/2005

Insulin-like growth factor regulation of mammary gland development and tumorigenesis

01.06.2005 | Oral Presentation | Sonderheft 2/2005

Targeting the cell cycle for prognosis and therapy of breast cancer

01.06.2005 | Oral Presentation | Sonderheft 2/2005

Apoptotic chemotherapies

01.06.2005 | Oral Presentation | Sonderheft 2/2005

High-resolution representational oligonucleotide microarray analysis and fluorescence in situ hybridization analysis of aneuploid and diploid breast tumors

01.06.2005 | Oral Presentation | Sonderheft 2/2005

Tailored therapies based upon tumor subtype biology

01.06.2005 | Oral Presentation | Sonderheft 2/2005

Expression profiling as a prognostic and predictive factor in breast cancer

01.06.2005 | Oral Presentation | Sonderheft 2/2005

Genomic profiling of breast cancer

01.06.2005 | Oral Presentation | Sonderheft 2/2005

A single nucleotide polymorphism in the HDM-2 gene regulates the p53 apoptotic response and influences the age of onset of cancers in humans: the SNP 309 HDM-2 polymorphism

01.06.2005 | Oral Presentation | Sonderheft 2/2005

Evading p53 action during tumor development and therapy

01.06.2005 | Oral Presentation | Sonderheft 2/2005

TP53 and additional pathways in therapy resistance

01.06.2005 | Oral Presentation | Sonderheft 2/2005

Dynamic imaging of plasticity and escape in tumor cell invasion

01.06.2005 | Oral Presentation | Sonderheft 2/2005

Role of HER2 in local relapse and metastasis

01.06.2005 | Oral Presentation | Sonderheft 2/2005

Molecular profiling of early breast cancer in relation to detection of micrometastases and outcome

01.06.2005 | Oral Presentation | Sonderheft 2/2005

Update on HER2-directed therapy

01.06.2005 | Oral Presentation | Sonderheft 2/2005

Targeting new therapies in combination with hormonal therapies for ER-positive breast cancer

01.06.2005 | Oral Presentation | Sonderheft 2/2005

Development of CDK inhibitors as cancer therapeutics

01.06.2005 | Oral Presentation | Sonderheft 2/2005

Genes, genomes, and cancer

01.06.2005 | Oral Presentation | Sonderheft 2/2005

The search for low-penetrance breast cancer genes

01.06.2005 | Oral Presentation | Sonderheft 2/2005

Functional genomic approaches to breast cancer

01.06.2005 | Oral Presentation | Sonderheft 2/2005

Proteomic approaches to early detection of breast cancer

01.06.2005 | Oral Presentation | Sonderheft 2/2005

Dissection of molecular pathways of cancer by high-throughput biochip technologies and RNA interference

01.06.2005 | Oral Presentation | Sonderheft 2/2005

Envisioning new targets and new approaches for molecular-based cancer therapeutics

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Cigarette smoking and breast cancer risk among non-drinking women

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Mutation screening of BRCA1, BRCA2 and CHEK2*1100delC in Slovak HBOC families

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Identification of novel sequence alterations and the functional analysis of the BRCA1 promoter/5'-UTR in families from Upper Silesia, Poland

01.06.2005 | Poster Presentation | Sonderheft 2/2005

High prevalence of a BRCA1 gene founder mutation, 5083del19, in unselected breast–ovarian cancer patients from Southern Italy: genotype–phenotype correlations

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Screening for germline rearrangements in BRCA1 and BRCA2in Norwegian families with breast or breast/ovarian cancer

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Hereditary breast cancer – a spectrum of pathogenic mutations and unknown variants of BRCA1 and BRCA2 genes in the Czech Republic: efficiency of testing and clinical follow-up

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Genetic determinants of breast cancer characteristics and outcome in women under 50 years of age

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Low-dose ionizing radiation significantly increases the risk of breast cancer among BRCA1/2 mutation carriers in the International BRCA1/2 Carrier Cohort Study (IBCCS)

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Clinical outcome for BRCA1 and BRCA2 mutation carriers after contralateral prophylactic mastectomy

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Oral contraceptives and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS)

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Genome-wide scanning for linkage in 56 Dutch breast cancer families selected for a minimal probability of being due to BRCA1 or BRCA2

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Who gets cancer?

01.06.2005 | Poster Presentation | Sonderheft 2/2005

DNA polymorphisms of several genes and predisposition to breast cancer

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Large-scale single nucleotide polymorphism analysis of candidates for low-penetrance breast cancer genes

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Chromosome-wide pharmacogenetics: localisation and linkage disequilibrium of genes coding for ROS metabolism and signalling

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Comparison of methods for pharmacogenomics: SNaPshot, SNPstream UHT, Nanogen, and RFLP

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Genetic polymorphisms in the 5' flanking region of glutathione S-transferase P1 affect promoter methylation

01.06.2005 | Poster Presentation | Sonderheft 2/2005

The rare ERBB2 variant Ile654Val is associated with an increased familial breast cancer risk

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Alpha-1 antitrypsin genotypes in breast cancer patients

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Association of NCOA3 (AIB1) polymorphisms with breast cancer risk

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Polymorphisms in the CRK gene and their association with breast cancer risk

01.06.2005 | Poster Presentation | Sonderheft 2/2005

High-density screening of the Zbtb7gene in breast cancer patients

01.06.2005 | Poster Presentation | Sonderheft 2/2005

ZBTB7 HapMap in a worldwide population study

01.06.2005 | Poster Presentation | Sonderheft 2/2005

A critical need for molecular markers of breast cancer risk and risk reduction

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Gene expression profiling in whole-blood samples from postmenopausal women exposed to hormone replacement therapy

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Effects of oestrogen on gene expression in the epithelium and stroma of the normal human breast

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Mammary development fate and breast cancer risk

01.06.2005 | Poster Presentation | Sonderheft 2/2005

BRCA1 directly modulates gene expression required for estrogen biosynthesis: a possible mechanism of tissue-specific tumor suppression

01.06.2005 | Poster Presentation | Sonderheft 2/2005

HER2 and ERβ2 downregulate estrogen-responsive element-mediated transcription activity of ERα-positive cells in response to estrogen stimulation

01.06.2005 | Poster Presentation | Sonderheft 2/2005

The anti-estrogen ICI 182,780, but not tamoxifen, inhibits the growth of MCF7 breast cancer cells refractory to long-term estrogen deprivation through downregulation of ER and IGF signalling

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Molecular prediction of tamoxifen resistance in breast cancer

01.06.2005 | Poster Presentation | Sonderheft 2/2005

The interaction of the ER with ERBB2 and PI3K results in elevated levels of AKT and p90RSK in tamoxifen-resistant MCF-7 cells

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Establishment and characterization of two breast cancer xenografts in immunodeficient mice for studies on hormone-dependent and hormone-independent tumor growth, progression and invasion

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Sex-hormone binding globulin receptor-mediated growth inhibition in breast cancer cells: a proteomics approach

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Identification of molecular apocrine breast tumours by microarray analysis

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Gene expression profiling to identify parity-induced changes in the human mammary gland

01.06.2005 | Poster Presentation | Sonderheft 2/2005

The intracellular domain of ErbB4 induces differentiation of mammary epithelial cells

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Essential functions of the Janus kinase 2 (Jak2) during mammary gland development and tumorigenesis

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Cooperation between extracellular signaling and intracellular Ras activation leads to immortalization and epithelial-to-mesenchymal transition of variant human mammary epithelial cells

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Ex vivo isolation of adult stem cells from normal and tumour mouse mammary parenchyma

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Myoepithelial cell layer disruption and human breast cancer invasion

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Imprint as a reliable diagnostic tool in breast cancer and possible usefulness for research purposes

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Immortalization-associated gene signature in breast cancer

01.06.2005 | Poster Presentation | Sonderheft 2/2005

6-(1-oxobutyl)-5,8-dimethoxy-1,4-naphthoquinone exerts anti-angiogenic activity via inhibition of vascular endothelial cell growth factor and hypoxia-inducible factor 1 alpha in hypoxia-exposed MCF breast cancer cells

01.06.2005 | Poster Presentation | Sonderheft 2/2005

HER2 upregulates fatty acid synthase and acetyl-CoA carboxylase at a translational level in breast cancer cells

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Altered signaling in anti-estrogen-resistant human breast cancer cells

01.06.2005 | Poster Presentation | Sonderheft 2/2005

HIN-1, an inhibitor of cell growth, invasion, and AKT1 activation

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Expression of STAT1 target genes and interferon gamma in human mammary carcinoma tissue

01.06.2005 | Poster Presentation | Sonderheft 2/2005

In vitro models for tumor protein d52 function in cancer cells

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Functional characterization of genes involved in the development of breast cancer

01.06.2005 | Oral Presentation | Sonderheft 2/2005

Abstract withdrawn

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Deletions at the chromosome 3 common eliminated region 1 on 3p21.3 in human breast tumors

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Protein expression and gene amplification of primary cyclins (A, B1, D1, D3and E) and secondary cyclins (C and H) in relation to prognosis in breast cancer patients

01.06.2005 | Poster Presentation | Sonderheft 2/2005

IL-8 is a novel marker for breast cancer

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Lack of evidence for nuclear IGFBP5 in mammary epithelial cells

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Identification of clinically relevant gene sets and pathways using functional models of breast tumor suppression

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Microcell-mediated transfer of chromosome 6 into the breast cancer cell line MDA-MB-231: a specific set of genes is involved in the reversion of the tumorigenic phenotype

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Epigenetic silencing of tropomyosin alters transforming growth factor beta control of cell invasion and metastasis

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Hypermethylation of cyclin D2 and DAP kinase is associated with the lobular subtype of breast cancer

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Methylation profiling of carcinogenesis-associated genes in sporadic breast cancer

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Expression profiling of Wnt pathway genes in breast cancer

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Real-time PCR-based expression profiling of BRCA1-induced genes in primary breast tumors

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Development of a rapid screening approach for candidate gene sets in cancer

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Application of microarray analyses to identify genes involved in radiation-induced fibrosis

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Gene expression studies in radiation-sensitive cell lines

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Breast tumors induced by high-dose radiation display similar genetic profiles

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Molecular characterization of breast cell lines: a tool for breast cancer studies

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Cell differentiation and dominant signaling pathway signatures in the molecular classification of human breast cancer cell lines

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Reproducibility of molecular portraits in early stage breast cancer

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Subclassification and molecular characterization of early stage breast carcinomas using Applied Biosystems Human Genome Survey Microarrays

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Lymph node metastases display gene expression profiles of their primary breast carcinomas

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Genome-wide expression profiling of microdissected human breast tumor cells: tumor classification predictive of metastases and clinical outcome

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Gene expression signature of hereditary breast cancer

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Comparison of the expression profile in breast cancer and ovarian cancer

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Comparative expressed sequence hybridisation revealed distinct chromosomal regions of differential gene expression in breast cancer subtypes

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Gene expression profiling in breast cancer challenges the existence of intermediate histological grade

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Promoter composition predicts gene classes in microarray expression analyses of breast cancer

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Identification of differentially expressed genes in canine mammary tumor cell lines using a newly developed canine-specific cDNA microarray

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Discovering genetic profiles by array-CGH in familial breast tumors

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Chromosomal imbalances mapped by array-based comparative genomic hybridization in an integrated approach to combat breast cancer in Denmark

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Outcome signature genes in breast cancer: is there a unique set?

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Mapping the location of recurring amplicons in array-CGH data

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Comparative genomic hybridization using oligonucleotide arrays and total genomic DNA

01.06.2005 | Poster Presentation | Sonderheft 2/2005

DNA copy number changes in breast cancer samples using array-CGH profiling

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Quality control of DNA with on-chip electrophoresis for oligonucleotide-array comparative genomic hybridization

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Predicting survival from gene expression data by generalized partial least squares regression

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Gene expression profiles and the TP53 mutation status are powerful prognostic markers of breast cancer

01.06.2005 | Poster Presentation | Sonderheft 2/2005

TP53 mutations among molecular subtypes of HER2-positive tumors

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Mutant p53 exerts its gain of function through activation of the NF-κB pathway

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Expression of wild-type and mutated TP53in breast carcinomas

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Independent prognostic value of somatic TP53gene mutations in 1794 breast cancer patients

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Prognostic value genotypes and LOH at TP53 codon 72 and TP53mutations in primary breast cancer

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Evaluation of the arrayed primer extension resequencing assay for TP53mutation detection

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Cancer gene mutation discovery and detection using array-based resequencing

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Detection of circulating cancer cells in peripheral blood as a prognostic factor in early breast cancer

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Detection of minimal disease in breast cancer

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Postoperative serum proteomic profiles and identification of biomarkers with prognosis value in high-risk early breast cancer patients

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Monitoring of minimal residual cancer in bone marrow in high-risk breast cancer patients treated with high-dose chemotherapy

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Hypoxia promotes invasion and metastasis of breast cancer cells by increasing lysyl oxidase expression

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Breast tumors induce the recruitment of AC133+KDR+ endothelial precursor cells mobilized by plasma vascular endothelial growth factor

01.06.2005 | Poster Presentation | Sonderheft 2/2005

The extracellular matrix composition and responsiveness to breast carcinoma therapy

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Characterization of extracellular matrix composition in breast carcinoma

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Brn-3b transcription factor in breast tumourigenesis: regulation of genes associated with growth and migration of cancer cells

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Identification of drug targets for the treatment of Basal-like tumors

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Determining the factors affecting breast cancer infectivity by oncolytic adenovirus

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Magnetic resonance spectroscopy of breast cancer tissue used for tumor classification and lymph node prediction

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Potentiated phospho-protein networks in cancer cells

01.06.2005 | Poster Presentation | Sonderheft 2/2005

A model of the BRCA1/BRCA2 network

01.06.2005 | Poster Presentation | Sonderheft 2/2005

High-throughput experimental verification of predicted tissue-specific and tumor-specific splice isoforms

01.06.2005 | Poster Presentation | Sonderheft 2/2005

RNA integrity number: towards standardization of RNA quality assessment for better reproducibility and reliability of gene expression experiments

01.06.2005 | Poster Presentation | Sonderheft 2/2005

Morphogenesis of the mammary gland and the role of keratin expression

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise